These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4959545

  • 1. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
    Wescott JW.
    J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
    [No Abstract] [Full Text] [Related]

  • 2. Intravesical treatment with thiotepa: an update review.
    Fosså SD.
    Prog Clin Biol Res; 1984 Dec; 162B():163-8. PubMed ID: 6438640
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F, Lalanne G, Pizza GC.
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Chemotherapy of bladder neoplasms--studies of preventive measures against recurrence of superficial bladder neoplasms].
    Okajima E, Motomiya Y, Ishuin M, Ikuma S, Ohara S.
    Nihon Rinsho; 1977 May; 35(5):1987-91. PubMed ID: 407385
    [No Abstract] [Full Text] [Related]

  • 10. Renal failure associated with the use of thio-tepa.
    Schellhammer PF.
    J Urol; 1973 Nov; 110(5):498-501. PubMed ID: 4201562
    [No Abstract] [Full Text] [Related]

  • 11. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
    Gavrell GJ, Lewis RW, Meehan WL, Leblanc GA.
    J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
    [Abstract] [Full Text] [Related]

  • 12. [Dibunol and thio-TEPA treatment of bladder tumors].
    Barsel' VA.
    Urol Nefrol (Mosk); 1978 Oct; (4):27-30. PubMed ID: 98889
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW, Prout GR, Smith W, Frable WJ, Minnis JE.
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract] [Full Text] [Related]

  • 16. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG, Boyd PJ, Mayo ME, Shuttleworth KE, Lloyd-Davies RW.
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Severe pancytopenia associated with the use of intravesical thio-TEPA.
    Watkins WE, Kozak JA, Flanagan MJ.
    J Urol; 1967 Oct; 98(4):470-1. PubMed ID: 4964489
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.